Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2009
12/10/2009US20090305256 DNA methylation biomarkers for lung cancer
12/10/2009US20090305255 Substrate Protein for M-Phase Kinase and use Thereof
12/10/2009US20090305254 Method and Apparatus for Assaying Test Substance in Sample
12/10/2009US20090305253 Methods and Compositions Related to the Modulation of Riboswitches
12/10/2009US20090305252 Methods and species-specific primers for detection and quantification of Streptococcus mutans and Streptococcus sanguinis in mixed bacterial samples
12/10/2009US20090305251 Brca1/brca2 screening panel
12/10/2009US20090305250 Determination of the biological function of a target gene in a cell
12/10/2009US20090305249 Method of detecting cyp2a6 gene variants
12/10/2009US20090305248 Methods for increasing accuracy of nucleic acid sequencing
12/10/2009US20090305247 Nanoparticle and methods therefor
12/10/2009US20090305246 Schizophrenia associated genes and markers
12/10/2009US20090305245 Method of Examining Zinc-Deficient Taste Disturbance
12/10/2009US20090305244 Selection, Propagation and Use of Mosaic Aneuploid Stem Cells
12/10/2009US20090305243 Oligonucleotides, Use Thereof, Detecting Method and Kit for Diagnosing the Presence of H5 and N1 Genes of the Influenza a Virus
12/10/2009US20090305242 Skin aging marker and technique for use thereof
12/10/2009US20090305241 DNA demethylases and uses thereof
12/10/2009US20090305240 Method for detection of microorganism and kit for detection of microorganism
12/10/2009US20090305239 Methods and compositions for determing a level of biologically active serum paraoxonase
12/10/2009US20090305238 Microarray Microcard
12/10/2009US20090305237 Quantification of nucleic acids and proteins using oligonucleotide mass tags
12/10/2009US20090305236 Methods of enriching fetal cells
12/10/2009US20090305235 Novel Targets For The Identification Of Antibiotics That Are Not Susceptible To Antibiotic Resistance
12/10/2009US20090305234 Specific DNAS for Epigenetic Characterisation of Cells and Tissues
12/10/2009US20090305233 Methods and Reagents for Polynucleotide Assembly
12/10/2009US20090305232 Peptides for Detection of Antibody to Porcine Reproductive Respiratory Syndrome Virus
12/10/2009US20090305231 Sensitive Immunoassays Using Coated Nanoparticles
12/10/2009US20090305230 Real Time Detection of Molecules, Cells and Particles Using Photonic Bandgap Structures
12/10/2009US20090305229 Multiplex detection of respiratory pathogens
12/10/2009US20090305228 Potentiation of Apoptosis by Monoclonal Antibodies
12/10/2009US20090305227 Hiv-1 latency model for high throughput screening
12/10/2009US20090305226 Biomolecular Recognition of Crystal Defects
12/10/2009US20090305223 Method and apparatus for evaluatiing interactions in isolated tissue
12/10/2009US20090304858 Phosphoadenylyl Sulfate Reductase Gene and Use Thereof
12/10/2009US20090304781 Master gene of arteriogenesis
12/10/2009US20090304778 Diagnostics and Methods for Removal and Detection of Interferents
12/10/2009US20090304765 R-ras activity in vascular regulation
12/10/2009US20090304736 Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera
12/10/2009US20090304732 Cryptosporidium Hominis Genes and Gene Products for Chemotherapeutic, Immunoprophylactic and Diagnostic Applications
12/10/2009US20090304728 Tem8 gene, expression forms and diagnostic and therapeutic uses thereof
12/10/2009US20090304714 IKKi Inhibitor Therapies and Screening Methods, and Related IKKi Diagnostics
12/10/2009US20090304709 Modulators of p-selectin glycoprotein ligand 1
12/10/2009US20090304708 Preparation for the Prevention and/or Treatment of a Tissue Change of Mesenchymal Origin
12/10/2009US20090304705 Biomarkers for chronic transplant dysfunction
12/10/2009US20090304704 Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash)
12/10/2009US20090304703 Compositions and methods for the diagnosis and treatment of immune disorders
12/10/2009US20090304702 Gene expressed in prostate cancer and methods of use
12/10/2009US20090304697 Identification and use of prognostic and predictive markers in cancer treatment
12/10/2009US20090304686 Interfering in activation of an immune cell by influencing interaction of lair and collagen
12/10/2009US20090304685 Anti-Factor Xlla Therapy
12/10/2009US20090304680 Diagnosis and treatment of kawasaki disease
12/10/2009US20090304675 Method of modulation of mullerian inhibitory substance (mis) receptor for the treatment of neurodegenerative diseases
12/10/2009US20090304674 Methods for treating disease by regulating cll cell survival
12/10/2009US20090304672 Adamts13 genes and proteins and variants, and therapeutic compositions and methods of utilizing the same
12/10/2009US20090304664 Modulators of alpha-synuclein toxicity
12/10/2009US20090304653 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
12/10/2009US20090304652 Identification and selection of stem cells being committed to differentiate to a specific type for obtaining a homogeneous population of stem cells
12/10/2009US20090304646 Multipotent/Pluripotent Cells and Methods
12/10/2009US20090304641 Methods and Compositions for Regulating Gene Expression
12/10/2009US20090304575 In vitro method for identifying compounds for cancer therapy
12/10/2009US20090304552 Discharge apparatus
12/10/2009US20090302211 Method and device for desorption ionization by liquid jet
12/10/2009US20090301880 Target genes for strain-specific diagnostic of ehrlichia ruminantium and use thereof
12/10/2009DE102008002978A1 Identifying species of Methylobacterium, comprises preparing crude extract from methylobacteria, amplifying 16S ribosomal RNA, carrying out restriction digest, analyzing restriction fragment, detecting restriction pattern and comparing
12/10/2009CA2763791A1 Pluripotency associated epigenetic factor
12/10/2009CA2728556A1 Method for assessing embryotoxicity
12/10/2009CA2727003A1 Organ-on-a-chip-device
12/10/2009CA2726979A1 Three dimensional tissues for high-throughput assays
12/10/2009CA2726817A1 Identification and use of prognostic and predictive markers in cancer treatment
12/10/2009CA2726699A1 Nucleic acids and methods for detecting turfgrass pathogenic fungi
12/10/2009CA2726598A1 Controllable assembly and disassembly of nanoparticle systems via protein and dna agents
12/10/2009CA2726531A1 Compositions and methods for classifying lung cancer and prognosing lung cancer survival
12/10/2009CA2726481A1 Detecting infection in reduced pressure wound treatment
12/10/2009CA2726426A1 Diffuse large b-cell lymphoma markers and uses therefor
12/10/2009CA2726128A1 Cell line, system and method for optical control of secondary messengers
12/10/2009CA2725634A1 Biomarker for assessing response to chymase treatment
12/10/2009CA2724552A1 Compositions and methods for detection of chromosomal aberrations with novel hybridization buffers
12/10/2009CA2723939A1 User interface for testing device
12/10/2009CA2721899A1 Salmonella detection assay
12/09/2009EP2131194A1 Improved electrochemical-sensor design
12/09/2009EP2130930A2 Electric substrate for use as a holder for biomolecules
12/09/2009EP2130929A1 Internally controlled multiplex detection and quantification of microbial nucleic acids
12/09/2009EP2130928A1 Nucleic acids and methods for detecting turfgrass pathogenic fungi
12/09/2009EP2130927A1 Method for amplification of dna fragment
12/09/2009EP2130926A2 Phage microarray profiling of the humoral response to disease
12/09/2009EP2130920A2 Beta-like glycoprotein hormone polypeptide and heterodimer
12/09/2009EP2130918A1 Method for creating a variant library of DNA sequences
12/09/2009EP2130917A1 Probe for detecting polymorphism in gene involved in immunity, and use thereof
12/09/2009EP2130914A1 Novel glycosyltransferase and polynucleotide encoding the same
12/09/2009EP2130913A1 Chip for sampling cell component, system for analyzing cell component and method of analyzing cell component using the same
12/09/2009EP2130835A1 Compound having structure derived from mononucleoside or mononucleotide, nucleic acid, labeling substance, and method and kit for detection of nucleic acid
12/09/2009EP2130558A1 Methods and devices for collecting, handling and processing mammary fluid samples for evaluating breast diseases, including cancer
12/09/2009EP2130548A2 Growth Hormone Releasing Peptides
12/09/2009EP2130043A1 Method for detecting fungal contamination
12/09/2009EP2129805A1 Bioassay system including optical detection apparatuses, and method for detecting biomolecules
12/09/2009EP2129803A2 Molecule attachment to nanoparticles
12/09/2009EP2129801A1 Tbc1d1 as a marker in the response to dietary fat and obesity
12/09/2009EP2129800A1 Method for identifying and selecting low copy nucleic acid segments
12/09/2009EP2129799A1 Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same
12/09/2009EP2129798A2 Organism-specific hybridizable nucleic acid molecule
12/09/2009EP2129796A2 New markers for cancer